ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
4830	Centers for Disease Control and Prevention	Html	en	Features and initial assessment of the Italian Behavioral Risk Factor Surveillance System PASSI, 2007-2008	null	Field Epidemiology Training 0.451662 National Health Plan 0.476005 data 0.514016 public health interventions 0.53736 PASSI Coordinating Group 0.509262 PASSI interviewers 0.487084 PASSI data 0.504179 public health departments 0.463315 regional coordinating groups 0.445954 PASSI d’Argento 0.470401 public health surveillance 0.476546 behavioral risk factors 0.449662 refusal rate 0.482231 World Health Organization 0.44528 response rate 0.544919 ongoing surveillance 0.441869 Progressi Delle Aziende 0.445544 PASSI sample 0.488143 regional PASSI coordinators 0.506695 National Health 0.4833 health status 0.481112 data collection process 0.474129 health unit staff 0.456623 PASSI national pool 0.543227 PASSI results 0.495912	public health agencies 0.457116 Behavioral Risk Factor 0.519495 public health policy 0.46979 local health unit 0.521494 public health staff 0.455222 Epidemiology Training Program 0.450714 health promotion 0.473998 national coordinating group 0.525673 National Statistics Institute 0.546109 Risk Factor Surveillance 0.543467 regional public health 0.484698 public health infrastructures 0.452861 surveillance systems 0.506736 local health units 0.672071 public health 0.985186 PASSI 0.737224 National Institute 0.613062 public health actions 0.473269 Delle Aziende Sanitarie 0.44554 eligible units 0.443544 data collection 0.485183 local public health 0.477063 PASSI supervisors 0.486748 recent National Health 0.481931	CLICK HERE
5310	Centers for Disease Control and Prevention	Html	null	Tuberculosis (TB) Vaccination	Tuberculosis (TB) vaccine info for parents, public, and health care professionals			CLICK HERE
7213	Centers for Disease Control and Prevention	Html	en	Babesiosis Surveillance - 18 States, 2011	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	County-level incidence rates 0.40424 red blood cells 0.350215 blood donors 0.455716 CDC 0.379605 supplemental data 0.417693 Babesia parasites 0.417625 symptom onset 0.571497 Babesia microti–endemic states 0.446754 genus Babesia 0.376904 transfusion-associated cases 0.368611 public health authorities 0.498772 Babesia duncani IFA 0.386371 probable cases 0.508515 Babesia microti DNA 0.387448 clinically manifest cases 0.348852 treatable tickborne disease 0.342106 median age 0.36743 patients 0.456664 severe cases 0.354007 human babesiosis 0.513699 tickborne disease 0.34526 persons 0.371263 babesiosis surveillance 0.558392 Babesia infection 0.621426 Elizabeth A. Bosserman 0.386089	clinical manifestations 0.385715 reported cases 0.385609 standard case definition 0.691593 transfusion-associated babesiosis 0.46717 babesiosis CRF 0.493896 national babesiosis surveillance 0.528689 reportable condition 0.34472 Babesia species 0.359346 Babesia spp. 0.343576 health departments 0.425322 intraerythrocytic Babesia organisms 0.385226 polymerase chain reaction 0.403672 Babesia laboratory data 0.441714 New York 0.369902 blood transfusion 0.358182 B. microti–endemic states 0.426767 cases 0.772537 babesiosis 0.910398 standard data collection 0.348326 symptom onset dates 0.54017 evidence-based prevention 0.435156 control measures 0.432429 Babesia microti immunoblot 0.389178 Ongoing national surveillance 0.480742	CLICK HERE
8222	Centers for Disease Control and Prevention	Html	en	Spina Bifida, Facts - NCBDDD - CDC	Spina bifida is a condition that affects the spine and is usually apparent at birth. It is a type of neural tube defect (NTD).	spina bifida 0.978795 early pregnancy 0.337138 Treatments page 0.319416 productive lives 0.31951 neural tube 0.383499 neural tube defects 0.334933 type 0.346163 small sample 0.320023 common types 0.322824 small gap 0.320521 triple screen 0.320605 AFP – AFP 0.334162 pregnancy 0.346789 image scan 0.32002 spina bifida lead 0.452469 clear pictures 0.319741 myelomeningocele 0.319136 severe disabilities 0.320549 prenatal tests 0.319862 average levels 0.32024 simple blood test 0.337753 unborn baby 0.324057 high level 0.342209 minor disabilities 0.320304 late childhood 0.338333	United States 0.320137 hot tub 0.319445 AFP 0.334632 amniotic fluid 0.319849 neural tube defect 0.341209 intellectual disabilities 0.323088 sac 0.327185 store brand acetaminophen 0.335624 AFP test 0.326721 spinal cord 0.412506 folic acid 0.38822 nerve damage 0.320852 medical condition―such 0.3197 folic acid daily 0.33939 hairy patch 0.319843 spine 0.325036 prenatal testing 0.320584 people 0.33755 birth defects 0.319629 doctor 0.327958 healthy pregnancy 0.319636 spina bifida occulta 0.584647 baby 0.393615 mildest type 0.322728	CLICK HERE
10691	Centers for Disease Control and Prevention	Html	en	Secondary Analysis Reports'Research' Communicating in the First Hours	The CERC training program educates people on the principles and application of crisis and emergency risk communication when responding to a public health emergency.	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
10826	Centers for Disease Control and Prevention	Html	en	PrEP for HIV Prevention	If you think you are at risk of getting HIV, ask your health care provider if PrEP is right for you. Along with other prevention methods like condoms, PrEP can offer good protection against HIV if taken every day.	ongoing substantial risk 0.53757 prevention options 0.528727 injection drug 0.616852 Mutually monogamous means 0.527936 health care provider 0.661619 heterosexual man 0.474466 needle-sharing injection drug 0.542531 repeat HIV test 0.675777 anal sex 0.47891 oral sex 0.477488 potential HIV exposure—such 0.670886 injection equipment 0.549412 postexposure prophylaxis 0.47993 HIV prevention methods 0.697016 STD testing 0.475881 Pre-exposure prophylaxis 0.489051 condoms 0.482981 greater protection 0.474144 PrEP support activities 0.697295 PrEP research 0.632756 sexual behaviors 0.4743 good protection 0.482267 PrEP education 0.637371 injection risk behaviors 0.536444	single high-risk event 0.528437 prevention strategy 0.480776 HIV infection status 0.661869 bisexual male partners 0.528689 Prescribe PrEP 0.639798 local health departments 0.521198 unknown HIV status 0.676651 sterile injection equipment 0.54676 illicit drugs 0.473418 HIV prevention efforts 0.659067 federally qualified health 0.515744 HIV risk reduction 0.659717 substantial risk 0.692296 PrEP 0.928946 people 0.51694 drug treatment 0.538936 PEP Q&A 0.47658 HIV protection 0.605805 PrEP awareness 0.638871 HIV 0.944141 mutually monogamous* relationship 0.535629 uninfected partner 0.475223 HIV testing 0.679894 drug treatment program 0.535747	CLICK HERE
11309	Centers for Disease Control and Prevention	Html	null	Seguridad de la vacuna contra la influenza	Información sobre la seguridad de la vacuna contra la influenza: preguntas y respuestas -- CDC			CLICK HERE
11577	Centers for Disease Control and Prevention	Html	en	NER - Peer-Reviewed Biomonitoring Articles | NNAL	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
13102	Centers for Disease Control and Prevention	Html	en	Interim Guidance on Follow-up of Close Contacts of Persons Infected with Novel Influenza A Viruses Associated with Severe Human Disease and on the Use of Antiviral Medications for Chemoprophylaxis	Guidance for follow-up and antiviral chemoprophylaxis of close contacts of cases of human infection with novel influenza A viruses associated with severe human disease, including H7N9 and HPAI H5N1. - CDC	avian influenza 0.71971 probable case 0.369592 influenza treatment 0.36188 limited non-sustained person-to-person 0.35146 novel influenza 0.906777 infection control 0.307052 non-sustained person-to-person transmission 0.349043 severe influenza 0.372659 inhaled zanamivir 0.319158 interim guidance 0.335585 exposure groups 0.314801 pandemic influenza 0.347443 oral oseltamivir 0.316642 probable novel influenza 0.448353 respiratory symptoms 0.364611 CDC’s Influenza 0.359324 human H5N1 virus 0.33062 pathogenic avian influenza 0.373609 probable cases 0.319237 CDC Influenza Division 0.41004 close contact 0.390878 Influenza Season 0.360752 influenza A virus 0.5604	New England journal 0.448636 Influenza Antiviral Medications 0.436207 World Health Organization 0.320074 H5N1 viruses 0.307459 seasonal influenza 0.400431 severe human disease 0.494158 acute uncomplicated influenza 0.423076 H5N1 case definitions 0.344737 virus infection 0.478944 antiviral chemoprophylaxis 0.367805 symptomatic H5N1 patient 0.301832 avian influenza home 0.396145 oseltamivir-resistant influenza 0.34711 human infections 0.342757 H7N9 virus 0.310325 seasonal influenza studies 0.397509 et al 0.456578 close contacts 0.428221 Avian Influenza AV 0.373017 H5N1 influenza morbidity 0.412151 influenza a viruses 0.478027 H5N1 virus infection 0.378089 human infection 0.404497	CLICK HERE
16242	Centers for Disease Control and Prevention	Html	en	Progress Toward Poliomyelitis Eradication - Pakistan,January 2015-September 2016 | MMWR	The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).	high-risk areas 0.487945 supplementary immunization activities 0.433829 environmental surveillance 0.734954 polio eradication 0.47638 independent WPV1 transmission 0.451812 WPV1 response efforts 0.438043 oral poliovirus vaccine 0.695786 endemic wild poliovirus 0.425815 routine vaccination coverage 0.501735 FATA 0.46965 injectable inactivated polio 0.426947 wild poliovirus type 0.532035 AFP cases 0.580743 SIAs 0.488866 United Nations Children 0.427447 adequate stool specimens§ 0.424321 Pakistan 0.608088 children 0.523425 immunization activities 0.435307 WPV1-positive environmental surveillance 0.434322 national immunization campaign 0.442456 Balochistan 0.425539 nonpolio AFP cases 0.511097 WPV1 cases 0.915366	public health 0.468963 WPV1 patients 0.427583 routine immunization services 0.660717 supplemental immunization activities 0.429953 period 0.441114 World Health Organization 0.61721 South Waziristan 0.443414 environmental samples 0.486442 fewer WPV1 lineages 0.436661 type 2-containing OPV 0.484673 KP 0.454469 polio cases 0.439161 AFP surveillance quality 0.463521 newly confirmed WPV1 0.432281 Emergency Operations Center 0.491733 acute flaccid paralysis 0.697791 public health practice 0.431895 AFP surveillance 0.718798 stool specimen timeliness 0.602422 adequate stool 0.511034 vaccine-derived poliovirus 0.429116 national routine vaccination 0.439913 environmental surveillance samples 0.518952	CLICK HERE